These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 25919760)

  • 61. Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?
    de Oliveira T; Engelbrecht S; Janse van Rensburg E; Gordon M; Bishop K; zur Megede J; Barnett SW; Cassol S
    J Virol; 2003 Sep; 77(17):9422-30. PubMed ID: 12915557
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human immunodeficiency virus reverse transcriptase and protease sequence database.
    Rhee SY; Gonzales MJ; Kantor R; Betts BJ; Ravela J; Shafer RW
    Nucleic Acids Res; 2003 Jan; 31(1):298-303. PubMed ID: 12520007
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Changes in human immunodeficiency virus type 1 Gag at positions L449 and P453 are linked to I50V protease mutants in vivo and cause reduction of sensitivity to amprenavir and improved viral fitness in vitro.
    Maguire MF; Guinea R; Griffin P; Macmanus S; Elston RC; Wolfram J; Richards N; Hanlon MH; Porter DJ; Wrin T; Parkin N; Tisdale M; Furfine E; Petropoulos C; Snowden BW; Kleim JP
    J Virol; 2002 Aug; 76(15):7398-406. PubMed ID: 12097552
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors.
    Gatanaga H; Suzuki Y; Tsang H; Yoshimura K; Kavlick MF; Nagashima K; Gorelick RJ; Mardy S; Tang C; Summers MF; Mitsuya H
    J Biol Chem; 2002 Feb; 277(8):5952-61. PubMed ID: 11741936
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.
    Pettit SC; Moody MD; Wehbie RS; Kaplan AH; Nantermet PV; Klein CA; Swanstrom R
    J Virol; 1994 Dec; 68(12):8017-27. PubMed ID: 7966591
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genetic Changes in HIV-1 Gag-Protease Associated with Protease Inhibitor-Based Therapy Failure in Pediatric Patients.
    Giandhari J; Basson AE; Coovadia A; Kuhn L; Abrams EJ; Strehlau R; Morris L; Hunt GM
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):776-82. PubMed ID: 25919760
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs.
    Su CT; Koh DW; Gan SK
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31489889
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human Immunodeficiency Virus Gag and protease: partners in resistance.
    Fun A; Wensing AM; Verheyen J; Nijhuis M
    Retrovirology; 2012 Aug; 9():63. PubMed ID: 22867298
    [TBL] [Abstract][Full Text] [Related]  

  • 69.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.